Back to search

Article

An 8-Gene Bevacizumab Resistance Signature Predicts Prognosis and Reveals Immunosuppressive Microenvironment in Colorectal Cancer

2026-05-20

Abstract excerpt

<h4>Background</h4> Bevacizumab resistance severely limits long-term efficacy in metastatic colorectal cancer (CRC). This study aimed to develop and validate a bevacizumab resistance-associated gene signature for prognosis prediction and immune microenvironment characterization in CRC. <h4>Methods</h4> Two GEO datasets (GSE19862, GSE86582) with bevacizumab response data and TCGA-COAD/READ RNA-seq data were analy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b8310daa-2665-50eb-8c11-d8b776a99080
DOI
10.64898/2026.05.17.725749
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An 8-Gene Bevacizumab Resistance Signature Predicts Prognosis and Reveals Immunosuppressive Microenvironment in Colorectal CancerDOI 10.64898/2026.05.17.725749
Select a neighboring publication to make it the new centre.